James C. Gale, Director at INDEVUS PHARMACEUTICALS INC (IDEV), sold 2,500,000 shares at $7.90 ($19.8M) on 2007-10-18, disclosed to the SEC on 2007-10-23.
Open-market sale of $19.8M IDEV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.90 | 36,048 | $285K | 1.4% |
| 2 | $7.90 | 151,498 | $1.2M | 6.1% |
| 3 | $7.90 | 160,256 | $1.3M | 6.4% |
| 4 | $7.90 | 302,868 | $2.4M | 12.1% |
| 5 | $7.90 | 395,292 | $3.1M | 15.8% |
| 6 | $7.90 | 634,217 |
| $5.0M |
| 25.4% |
| 7 | $7.90 | 819,821 | $6.5M | 32.8% |
| Total | $7.90 avg | 2,500,000 | $19.8M | 100% |
| Filing → |
| TLGT | BUY | 2017-11-13 | $57K | — | Filing → |
| TLGT | BUY | 2016-03-14 | $74K | — | Filing → |
| IG | BUY | 2015-05-01 | $151K | — | Filing → |